Entrada Therapeutics (TRDA) Prepaid Assets (2020 - 2026)
Entrada Therapeutics (TRDA) posted quarterly Prepaid Assets of $11.2 million for Q1 2026, down 39.76% year-over-year from $18.6 million in Q1 2025, and up 28.75% quarter-over-quarter from $8.7 million in Q4 2025.
Entrada Therapeutics (TRDA) Prepaid Assets (2020 - 2026) Analysis & Trends
Entrada Therapeutics' Prepaid Assets history runs 7 years deep, the most recent figure standing at $11.2 million for Q1 2026.
- In Q1 2026, Prepaid Assets fell 39.76% year-over-year to $11.2 million; the TTM figure through Mar 2026 stood at $11.2 million (down 39.76% YoY), while the FY2025 annual figure was $8.7 million, down 46.71% from the prior year.
- Prepaid Assets for Q1 2026 stood at $11.2 million, up from $8.7 million in the prior quarter.
- The five-year high for Prepaid Assets was $24.4 million in Q3 2023, with the low at $8.7 million in Q4 2025.
- The 5-year median for Prepaid Assets is $12.1 million (2024), against an average of $13.8 million.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets soared 1316.19% in 2022, then sank 46.71% in 2025.
- Entrada Therapeutics' Prepaid Assets stood at $21.2 million in 2022, then tumbled by 43.66% to $11.9 million in 2023, then soared by 37.21% to $16.4 million in 2024, then tumbled by 46.71% to $8.7 million in 2025, then increased by 28.75% to $11.2 million in 2026.
- Business Quant data shows TRDA's Prepaid Assets at $11.2 million in Q1 2026, $8.7 million in Q4 2025, and $10.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Entrada Therapeutics | 290.47 Mn | 290.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.88 Mn |
| Mar 31, 2026 | 11.23 Mn |
| Dec 31, 2025 | 8.72 Mn |
| Sep 30, 2025 | 10.22 Mn |
| Jun 30, 2025 | 13.95 Mn |
| Mar 31, 2025 | 18.63 Mn |
| Dec 31, 2024 | 16.36 Mn |
| Sep 30, 2024 | 13.39 Mn |
| Jun 30, 2024 | 12.12 Mn |
| Mar 31, 2024 | 9.24 Mn |
| Dec 31, 2023 | 11.92 Mn |
| Sep 30, 2023 | 24.44 Mn |
| Jun 30, 2023 | 9.66 Mn |
| Mar 31, 2023 | 16.21 Mn |
| Dec 31, 2022 | 21.16 Mn |
| Sep 30, 2022 | 19.16 Mn |
| Jun 30, 2022 | 9.65 Mn |
| Mar 31, 2022 | 8.81 Mn |
| Dec 31, 2021 | 7.64 Mn |
| Sep 30, 2021 | 1.35 Mn |